Mid-Afternoon Market Update: Sage Therapeutics Drops After Brexanolone Drug Fails Phase III Testing; Aldeyra Therapeutics Shares Gain
September 12, 2017 at 14:41 PM EDT
Toward the end of trading Tuesday, the Dow traded up 0.27 percent to 22,116.82 while the NASDAQ climbed 0.18 percent to 6,443.63. The ...
